FFM
ORKA

Fairmount Funds Management’s Oruka Therapeutics ORKA Stock Holding History

Fairmount Funds Management’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$182M Hold
3,705,262
– – 13.13% 5
2025
Q4 		$112M Hold
3,705,262
– – 8.55% 5
2025
Q3 		$71.3M Buy
3,705,262
+333,340
+10% +$4.94M 6.41% 7
2025
Q2 		$37.8M Hold
3,371,922
– – 4.9% 11
2025
Q1 		$34.6M Hold
3,371,922
– – 5.37% 10
2024
Q4 		$65.4M Buy
3,371,922
+160,000
+5% +$3.9M 6.5% 8
2024
Q3 		$78.7M Buy
+3,211,922
New +$112M 6.38% 7

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return